Your Thyroid Problem Is Actually A Conversion Problem

Most people with thyroid symptoms never get told that their thyroid might be doing its job just fine.

The problem is not always production. Most of the time, it is conversion.

Here is the full chain so you have the map. Your hypothalamus signals your pituitary, your pituitary releases something called TSH, which stands for thyroid stimulating hormone and it is the signal your pituitary sends when it wants your thyroid to produce more hormone. Your thyroid responds by making mostly T4, which is the storage form of thyroid hormone. T4 does not do much on its own. It has to be converted into T3, which is the active form that actually enters your cells and runs your metabolism. Then your cells respond, and the hypothalamus and pituitary sense that response and dial back TSH accordingly.

That loop is what most doctors are measuring when they order a thyroid panel. They pull TSH, see it in range, and stop there.

The problem is that TSH only tells you how the pituitary perceives what is happening. It does not tell you how much T4 is circulating in your blood, how much of that T4 is being converted to T3, or whether your cells are actually receiving usable signal. A 2011 study in PLoS ONE looked at patients who had no thyroid at all and were fully dependent on levothyroxine, which is a synthetic T4 medication, and found that more than 20 percent of them had abnormal free T3 or free T4 levels despite having a completely normal TSH. Normal TSH, broken conversion. The pituitary was satisfied. The patient was not.

So why does conversion break down?

The conversion from T4 to T3 happens through enzymes called deiodinases, which are proteins that strip an iodine molecule from T4 to produce the active T3 your cells can use. There are three types. The ones most relevant here are type 1 deiodinase, which is concentrated in your liver and kidneys, and type 2 deiodinase, which is distributed throughout your skeletal muscle tissue. Between 70 and 90 percent of the T3 your body uses every day comes from this peripheral conversion process, meaning it never came from your thyroid at all. It was made in your tissues.

That one fact changes the entire frame of the problem.

If most of your active thyroid hormone is being made in your muscle, liver, and kidneys, then the health of those tissues is directly tied to how well your thyroid system functions. More lean muscle mass means more tissue running type 2 deiodinase and more capacity to convert T4 into usable T3. Less muscle, or muscle that is inflamed and metabolically impaired, means less conversion happening throughout the day.

This is why exercise shows up in the thyroid literature in a way most people do not expect. A 2025 cross sectional study in Biomolecules looked at patients with Hashimoto's thyroiditis, which is the autoimmune form of hypothyroidism, and found that recreational exercise was associated with meaningfully lower levels of inflammatory markers including interleukin-6 and tumor necrosis factor alpha. These are the same inflammatory signals that suppress deiodinase activity and push conversion toward reverse T3 instead of active T3. Reverse T3 is a dead end metabolite. It looks like T3 on a lab panel if your doctor is not checking correctly, but it cannot activate your cells.

Cortisol does the same thing. Chronic stress elevates cortisol, cortisol inhibits the deiodinase enzymes, and conversion shifts toward the inactive form. This is why people going through prolonged stress periods often start developing hypothyroid symptoms, fatigue, cold intolerance, brain fog, despite labs that look normal.

Selenium is also part of the mechanism here. Deiodinase enzymes are selenoproteins, meaning they require selenium to function. Without adequate selenium in the diet, the enzymes that run conversion slow down regardless of how much T4 your thyroid is making.

Protein sits underneath all of this. The enzymes themselves require amino acids to be synthesized and maintained. The muscle tissue that houses type 2 deiodinase is built from dietary protein. A case report published in Cureus in 2025 documented a Hashimoto's patient who resolved her primary symptoms through a structured high protein nutritional protocol without changing her medication. That is a single case, not a clinical trial, but the mechanism behind it is consistent with what the enzyme literature describes.

This is why the fix for a conversion problem cannot be a prescription for more T4. If your deiodinase enzymes are impaired by stress, selenium deficiency, chronic inflammation, or poor muscle mass, giving your body more T4 does not solve anything. You have just increased the substrate going into a broken conversion system.

The American Thyroid Association guidelines currently recommend using TSH as the primary monitoring tool and do not include routine free T3 or reverse T3 testing in the standard protocol. The argument is that TSH is a sensitive and reliable downstream marker. And it is, for production problems. But for conversion problems, it is looking at the wrong part of the chain.

When lifestyle changes are not enough and symptoms persist, the clinical literature points toward something called liothyronine or T3 supplementation, which is direct supplementation with the active hormone rather than the precursor. A 2022 study in Frontiers in Endocrinology looked at female hypothyroid patients who still had residual symptoms despite normal TSH on levothyroxine alone, and found that adding T3 to their protocol led to meaningful improvements in quality of life scores. The body was bypassing the conversion step entirely.

The thyroid is not just a gland. It is the endpoint of a metabolic system that runs through your muscle, your liver, your stress response, and your diet. Every part of that system matters for the final output.

Treating the gland without treating the system is like replacing the fuel injector in a car when the problem is actually the fuel.

---

References

1. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R. (2011). Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients. PLoS ONE 6(8):e22552. PMC3148220.
2. Cited for: the >20% of patients with abnormal FT3 or FT4 despite normal TSH on levothyroxine.
3. Limbaugh SL, Ennessy LA, Davis KS, Allen VT. (2025). Nutrition Based, High Protein Adjunct Therapy for Hashimoto's Thyroiditis: A Case Report. Cureus 17(9):e91597. PMC12495900.
4. Cited for: protein protocol resolving Hashimoto's symptoms.
5. Vuletić M, Žnidar V, Barić Žižić A, et al. (2025). Recreational Exercise and Inflammatory Patterns in Hashimoto's Thyroiditis: Observations from a Cross Sectional Study. Biomolecules 15(11):1510. PMC12650045.
6. Cited for: exercise reducing inflammatory markers in Hashimoto's patients.
7. Bjerkreim BA, Hammerstad SS, Gulseth HL, et al. (2022). Effect of Liothyronine Treatment on Quality of Life in Female Hypothyroid Patients With Residual Symptoms on Levothyroxine Therapy. Frontiers in Endocrinology 13:816566. PMC8902821.
8. Cited for: clinical evidence that adding T3 improves quality of life in patients with residual symptoms.
9. Lindner HH. (2025). Clinical thyroidology: beyond the 1970s' TSH T4 Paradigm. Frontiers in Endocrinology 16:1529791. PMC12234311.
10. Cited for: critique of the TSH only diagnostic model. Note: single author opinion piece.
11. European Thyroid Journal. Role of hepatic deiodinases in thyroid hormone homeostasis. PMC10160546.
12. Cited for: D1 distribution in liver and kidney, D2 distribution in skeletal muscle.
13. ScienceDirect Topics. Thyroxine Deiodinase.
14. Cited for: the 70-90 percent peripheral conversion figure.
15. Pituitary Foundation. Hormone Replacement Medication Interactions.
16. Cited for: thyroid hormone status affecting IGF-1 levels.
17. American Thyroid Association Guidelines on Treatment of Hypothyroidism.
18. Cited for: current guideline recommending TSH for monitoring without routine FT3 or rT3 testing.

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness